[email protected] (US) / [email protected]    Tel: (781) 999-4286 / (781) 999-5354
Home > Company Profile

Company Profile

Who are we?

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain, professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening.

TargetMol has evolved into one of the biggest global small molecule supplier with over 4000 products in stock and a customer base in 40+ countries. TargetMol serves three major client groups: Research laboratories, hospitals; Pharmaceutical industry in the process from lead discovery through to pre-clinical stages; Laboratory & diagnostic reagent producers.

TargetMol offers a wide range of high quality research chemicals including novel life-science reagents, inhibitors, activator, APIs and natural compounds for laboratory and scientific use. Our customer service and technical support teams have many years’ experience in the life science and Pharm industry. TargetMol will be a sincere and trustworthy partner for you and we are dedicated to be A Drug Screening Expert.

What can we do?

We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Who we are serving?

Drug screening – drug design and virtual screening, target validation, model establishment, high-throughput screening, structure optimization

Pharmacological research – in vivo and in vitro testing of compounds to identify new uses for known drugs

Signaling pathways – stem cell, protein tyrosine kinase, epigenetics, GPCR, MAPK signaling

Cell research – pluripotent stem cell induction, cell signaling transduction, cell inflammation, oncology